A method for the parallel solid phase synthesis (SPS) of iodinated analogues of sanofi-aventis' type 1 cannabinoid (CB 1 ) receptor inverse agonist rimonabant (acomplia ® ) has been developed. The method allows the synthesis of a range of C3 amide/hydrazide derivatives from a resin-bound C3 ester precursor. The C-Ge linkage to the Hypogel ® -200 resin is stable to the diversification conditions but allows ipso-iododegermylative cleavage using NaI/NCS even for the products containing the oxidatively labile hydrazide moiety.
Positron emission tomography (PET) and single photon emission computerized tomography (SPECT) are noninvasive, high resolution 'molecular' imaging techniques used clinically for diagnosis and monitoring of many medical disorders.
1 The short-lived positron or gammaray emitting nuclei required for these techniques [e.g. 124 I (t ½ 4.2 d) and 123 I (t ½ 13.2 h), respectively] must be incorporated into the appropriate imaging molecules regioselectively and rapidly.
2 For radio-iodinated aryl iodides this normally entails ipso-iododestannylation of an aryl trialkyltin precursor (e.g. ArSnMe 3 or ArSn n Bu 3 ) by radiolabelled KI or NaI in the presence of an oxidant followed by HPLC purification to remove all traces of toxic tin residues from the product. We envisaged that by employing an aryl labelling precursor bound to an insoluble polymer via a trialkylgermane linker it would be possible to effect analogous ipso-iododegermylative labelling thereby obviating the need for the radiochemist to handle tincontaining materials and also the requirement for any post reaction purification. Fig. 1 ) have proved to be viable for PET and SPECT imaging of CNS activity but an optimal ligand has yet to be identified. 14 
Figure 1 Structures of rimonabant, AM251 & AM281
All reported rimonabant-derived radioiodinated ligands contain the labelled iodine atom in place of the chlorine atom in the C5 aryl ring; this substitution marginally reduces affinity but increases selectivity for binding at CB 1 vs. CB 2 . Their synthesis involves solution phase Pd(0)-mediated stannylation of an arylbromide late intermediate (e.g. 5 → 6, Scheme 1) then ipsoiododestannylation with a radiolabelled iodonium source (e.g. 6 → 1c, Scheme 1).
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Scheme 1 Standard synthesis of a radio-iodinated rimonabant analogue (e.g. AM281)
Experimental structure activity relationship (SAR) data, particularly in the context of previous attempts to develop effective PET ligands, show that the nature of the C3 hydrazide moiety has a profound effect on the affinity and biodistribution of rimonabant analogues for the CB 1 receptor, 9a, 15 making this unit an attractive target for variation to allow imaging agent optimization. Consequently, our plan was to prepare a 1,5-diarylpyrazole bound to an insoluble polymer support by a Ge linker (attached at the para position of the C5 aryl ring) and containing an ester at C3 that could be readily converted via parallel SPS into an array of hydrazide/amide derivatives. Such a strategy would allow the rapid preparation of an array of potential imaging agents from a single functionalized polymer provided that the Ge-linker was stable to the C3 diversification protocol and ipso-iododegermylation could be achieved in the presence of an oxidatively labile 16 hydrazide moiety. Arylgermanes are uniquely stable towards basic and nucleophilic conditions as compared to arylstannane and arylsilane congeners 17 so we were confident of the former requirement but we were cognizant that arylgermanes undergo S E Ar reactions less rapidly than arylstannanes (due to their lesser β-effect) 18 and so we expected careful optimization of the cleavage conditions would be required to allow rapid clean cleavage without side-reactions (Scheme 2).
Scheme 2 Planned approach to an array of iodinated rimonabant analogues 1 via ipso-iododegermylation of functionalsed polymers prepared by parallel SPS.
Our initial studies used a solution phase model system 11 which was prepared by transmetallation of lithiated 1,5-diarylpyrazole tert-butyl ester 4 (Scheme 1) with germylbromide 9 followed by LiHMDS-mediated amidation 19 with N-aminomorpholine. The ethoxyethyl
